Serum Ropivacaine Concentrations in Pediatric Patients Receiving Continuous Wound Catheter Analgesia

Completed

Conditions studied: Alveolar Bone Grafting, Alveolar Cleft Grafting

In brief

The primary investigators in this study plan to investigate serum concentrations of ropivacaine in pediatric patients who already receive as standard of care a continuous wound catheter after an iliac crest alveolar bone graft harvest for completion of a previous cleft palate repair. The goals of this study are 1) to determine serum concentrations (free, unbound) of ropivacaine 2) To evaluate pain scores during the perioperative period to determine efficacy of wound catheters for postoperative analgesia for iliac crest bone graft harvest.

Key facts

Study ID

NCT02526563

Run by

University of Pittsburgh

People needed

4

Starts

2015-08-01

Expected to finish

2018-08-01

Last updated by the study team

2019-08-05

Who can join

Age: 5 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Inclusion criteria is any patient age ranging from 5 to 18 years of age that is scheduled for an iliac crest bone harvest that requires an iliac crest wound catheter

You may not qualify if…

• Patient or parent/guardian refusal
• Ropivacaine allergy

Where it is running

• The Children's Hospital of Pittsburgh — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.